Pharmaceutical Manufacturing

Pharmaceutical Manufacturing

Brief Excerpt from Industry Overview Chapter:

Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol Myers Squibb, Eli Lilly, Johnson & Johnson, Merck, and Pfizer (all based in the US), as well as AstraZeneca and GlaxoSmithKline (both based in the UK), Bayer (Germany), Novartis and Roche (both based in Switzerland), and Sanofi (France).

COMPETITIVE LANDSCAPE

Pharmaceutical manufacturers compete to discover and commercialize ever-more effective medicines. Companies focus on the most profitable markets, where demand for treatment is high. Key areas of development include cardiovascular, cancer, and diabetes medications, as increases in the number of elderly and obese patients fuel disease growth in these categories. Companies may also focus on rare disease categories, where available treatments are limited or nonexistent and opportunities exist for expedited approvals and profitable pricing.

PRODUCTS, OPERATIONS & TECHNOLOGY

Pharmaceutical preparations that affect the central nervous system account for about 20% of the industry revenue, followed by preparations that affect neoplasm (more than 10% of industry revenue). Other products include vitamin, nutrient, and hematinic preparations (about 10%), respiratory system pharmaceutical preparation (about 10%).